InCarda Therapeutics featured in Endpoints News
InCarda Therapeutics and our President & CEO Grace Colón were featured in a recent post on Endpoints News. The post highlights InCarda’s Raise of $30 Million Through First Close of Series C Equity Financing. More information below:
“This is especially exciting at a time when more and more patients are using mobile, wearable and portable devices for their arrhythmia,” Colón said. “We feel that all of that excitement and awareness that’s out there is great for patients, however, they don’t have immediate clinical utility, and that’s something that we’ll be able to provide.”
Grace E. Colón, Ph.D.
President & Chief Executive Officer